EC Number |
IC50 Value |
IC50 Value Maximum |
Inhibitor |
Reference |
---|
3.2.1.114 | 0.00025 |
- |
(1S,2R,5R,8R,8aR)-5-[2-(4-tert-butylphenyl)ethyl]octahydroindolizine-1,2,8-triol |
pH 5.75, 25°C |
708117 |
3.2.1.114 | 0.000044 |
- |
(1S,2R,5S,8R,8aR)-5-[2-(4-tert-butylphenyl)ethyl]octahydroindolizine-1,2,8-triol |
pH 5.75, 25°C |
708117 |
3.2.1.114 | 0.8 |
- |
(2R,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol |
- |
682766 |
3.2.1.114 | 0.72 |
- |
(2R,3R,4S)-2-([[(1S)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol |
- |
682766 |
3.2.1.114 | 1 |
- |
(2R,3R,4S,5R)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)-5-methylpyrrolidine-3,4-diol |
- |
682766 |
3.2.1.114 | 0.025 |
- |
(2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol |
extracted from endothelial cells HCEC |
696732 |
3.2.1.114 | 0.05 |
- |
(2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol |
extracted from human glioblastoma cells LN18 |
696732 |
3.2.1.114 | 0.05 |
- |
(2S,3R,4S)-2-([[(1R)-2-hydroxy-1-phenylethyl]amino]methyl)pyrrolidine-3,4-diol |
extracted from human glioblastoma cells LNZ308 |
696732 |
3.2.1.114 | 0.075 |
- |
(2S,3R,4S)-2-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]pyrrolidine-3,4-diol |
extracted from endothelial cells HCEC |
696732 |
3.2.1.114 | 0.075 |
- |
(2S,3R,4S)-2-[([(1R)-2-[(4-bromophenyl)(hydroxy)methoxy]-1-phenylethyl]amino)methyl]pyrrolidine-3,4-diol |
extracted from human glioblastoma cells LNZ308 |
696732 |